11 participants
A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-11-28
- Start Date:
- 2012-10-31
- Completion:
- 2015-09-30
Conditions
- Rheumatoid Arthritis
Interventions
- DRUG